Faculty

Institution

Unit

Venue

Asif Rashid

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Pathology

Department Of Pathology And Genomic Medicine

Department Of Surgical Pathology

The University of Texas MD Anderson Cancer Center

Asif Rashid is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on gastrointestinal and hepatobiliary pathology, with specific interests in hepatocellular carcinoma, tumor biology, and the molecular pathogenesis of liver cancer. His recent work includes genome-wide association studies identifying high-impact susceptibility loci for hepatocellular carcinoma in North America, clinicopathologic characterization of colorectal carcinomas with KRAS codon 146 mutations, and evaluating circulating Fibroblast Growth Factor 21 (FGF21) as a prognostic biomarker in hepatocellular carcinoma. He has also investigated immune checkpoint inhibitor-mediated hepatotoxicity and developed primary colon and duodenal tumor cultures from the Apc-mutant Pirc rat for screening preventive agents.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Asif Rashid

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology cancer research pathology tumor biology cancer biology health sciences molecular cancer oncogenes genetics hepatology cancer genetics gastrointestinal oncology carcinogenesis liver cancer cancer cells medicinal research hepatocellular carcinoma cancer care epidemiology gastroenterology surgical oncology histopathology cancer genomics molecular diagnostics surgical pathology digestive diseases cancer risk colorectal cancer cancer discovery molecular gastroenterology pancreatic cancer vascular biology tumoral pathology cancer treatment esophageal cancer metastasis molecular pathology epigenetics cancer imaging population-based study endocrine oncology pancreatic ductal adenocarcinoma thoracic oncology biliary tract cancers clinical evidence biliary tract cancer gastrointestinal surgery malignant disease prognostic evaluation human pathology cancer management biliary cancer gallbladder cancer esophagus prognostic biomarkers disease progression medical genetics clinical pathology clinical gastroenterology epigenetic changes endocrine-related cancers cpg island methylation prognostic significance epidemiology of cancer neuroendocrine disorders cancer prevention disease risk assessment neoadjuvant therapy preoperative chemoradiation genetic alterations gastric cancer microsatellite instability population-based case-control study neuroendocrine tumors poor prognosis neoadjuvant chemoradiation

Notable Scholarly Works

Notable Federal Grants

Collaborators

322 Unraveling the Nexus: Tumor Mutational Burden, Pd-L1 Expression and Oncogene Specific Alterations in Cytology Specimens of Non-Small Cell Lung Cancer. Laboratory Investigation (2025)

oncogenespd-l1 expressionpathologytumor biologycell biologylung cancermolecular diagnosticsthoracic oncologycytology specimenscancer geneticscancer genomicstumor mutational burden

3. Clinicopathologic Features and Outcomes for Colorectal Carcinomas With Kras Codon 146 Mutations. Cancer Genetics (2025)

oncogenescolorectal cancerpathologycolorectal carcinomasmolecular pathologycancer researchmolecular diagnosticsclinicopathologic featurescancer geneticsoncologygenetics

Circulating Fibroblast Growth Factor 21 (Fgf21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma (2025)

oncogenespathologyliver cancerdiagnostic biomarkercell biologyhepatologymolecular cancerfibroblast growth factorscancer researchbiomarkershepatocellular carcinoma

Corrigendum to “Prognostic Model for Patient Survival in Primary Anorectal Mucosal Melanoma: Stage at Presentation Determines Relevance of Histopathologic Features” [Modern Pathology 33 (2020) 496–513]. Modern Pathology (2025)

presentation determines relevancepathologyradiation oncologymelanomasurgical pathologyprognostic modelhistopathologypatient survivalanatomical pathologyoncologytumoral pathology

Development of Primary Colon and Duodenal Tumor Cultures From the Apc-Mutant Pirc Rat for Screening Preventive Agents. Journal of Cancer Prevention (2025)

colorectal cancerpathologygastrointestinal oncologygastroenterologyduodenal tumor culturesdigestive diseasescancer researchinflammatory bowel diseasepharmacologymolecular gastroenterologyapc-mutant pirc ratprimary colon

Immune Checkpoint Inhibitor-Mediated Hepatotoxicity: Personalized Management Based on Evolving Biochemical Behaviors. (2025)

liver physiologydrug-induced liver injurycell deathimmunologypersonalized managementhepatologyimmunotherapypharmacologyexperimental medicineevolving biochemical behaviorshepatotoxicity

Genome-Wide Association Study Identifies High-Impact Susceptibility Loci for Hcc in North America. Hepatology (2024)

Manal M. HassanDonghui LiYounghun HanJinyoung ByunRikita I. HatiaErping LongJiyeon ChoiRobin Kate KelleySean P. ClearyAnna S. LokPaige BracciJennifer B. PermuthRoxana BucurJian-Min YuanAmit G. SingalPrasun K. JalalR. Mark GhobrialRegina M. SantellaYuko KonoDimpy P. ShahMindie H. NguyenGeoffrey LiuNeehar D. ParikhRichard KimHui-Chen WuHashem El-SeragPing ChangYanan LiYun Shin ChunSunyoung S. LeeJian GuErnest HawkRyan SunChad HuffAsif RashidHesham M. AminLaura BerettaRobert A. WolffSamuel O. AntwiYehuda PattLu-Yu HwangAlison P. KleinKaren ZhangMikayla A. SchmidtDonna L. WhiteJohn A. GossSaira A. KhaderiJorge A. MarreroFrancisco G. CigarroaPankil K. ShahAhmed O. KasebLewis R. RobertsChristopher I. Amos

high-impact susceptibility lociepidemiologyhepatologyhematologygenomicsnorth americagenome-wide association studieshuman geneticsgenetics

Microsatellite Instability and High Tumor Mutational Burden Detected by Next Generation Sequencing Are Concordant With Loss of Mismatch Repair Proteins by Immunohistochemistry. Cancer Genetics (2024)

Richard K YangHector AlvarezAntony San LucasSinchita Roy-ChowdhuriAsif RashidHui ChenLeomar Y BallesterKeith SweeneyMark J RoutbortKeyur P PatelRajyalakshmi LuthraL Jeffrey MedeirosGokce A Toruner

mismatch repair proteinscancer geneticsmicrosatellite instability

Severe Febrile Neutropenia and Pancytopenia in a Patient With Advanced Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab: A Case Report. Journal of Gastrointestinal Oncology (2024)

Shadi ChamseddineMichael LaPelusaKristen CarterVan NguyenYehia I MohamedYara SakrCristhiam M Rojas-HernandezRikita I HatiaManal HassanJohn A GossKhaled M ElsayesAsif RashidRyan SunHop Sanderson Tran CaoHesham M AminAhmed O Kaseb

gynecologic oncologypathologysurgical oncologyclinical microbiologyinfectious diseasesgastroenterologycancer immunotherapycancer researchhepatobiliary tumorshepatocellular carcinomaoncogenesradiation oncologygastrointestinal oncologycancer careliver cancerliver diseasehepatologyfebrile neutropeniaadvanced hepatocellular carcinomaoncology

Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Patients With Resectable Hepatocellular Carcinoma. Oncology (2024)

Michael LaPelusaShadi ChamseddineHop Sanderson Tran CaoLianchun XiaoElshad HasanovPriya BhosaleHesham M AminYehia I MohamedBetul Gok YavuzYara SakrLi XuIan HuSunyoung S LeeDivya SakamuriSonali JindalVan NguyenMichael A CurranRyan SunAsif RashidDan Gabriel DudaPadmanee SharmaAliya QayyumAhmed Omar Kaseb

therapy resistanceimmunologyfunctional imagingcarcinogenesiscancer discoverypharmacologyvascular biologynovel therapiescancer cellsmedicinal researchmolecular imagingneoadjuvant nivolumabresectable hepatocellular carcinomasystems biologytumor microenvironmentprognostic evaluationhistopathologytumor heterogeneitytherapeutic efficacyneuro-oncology

1
2
3
4
5
37
10 / page

Asif Rashid

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Pathology

Department Of Pathology And Genomic Medicine

Department Of Surgical Pathology

The University of Texas MD Anderson Cancer Center

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Asif Rashid

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

322 Unraveling the Nexus: Tumor Mutational Burden, Pd-L1 Expression and Oncogene Specific Alterations in Cytology Specimens of Non-Small Cell Lung Cancer. Laboratory Investigation (2025)

oncogenespd-l1 expressionpathologytumor biologycell biologylung cancermolecular diagnosticsthoracic oncologycytology specimenscancer geneticscancer genomicstumor mutational burden

3. Clinicopathologic Features and Outcomes for Colorectal Carcinomas With Kras Codon 146 Mutations. Cancer Genetics (2025)

oncogenescolorectal cancerpathologycolorectal carcinomasmolecular pathologycancer researchmolecular diagnosticsclinicopathologic featurescancer geneticsoncologygenetics

Circulating Fibroblast Growth Factor 21 (Fgf21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma (2025)

oncogenespathologyliver cancerdiagnostic biomarkercell biologyhepatologymolecular cancerfibroblast growth factorscancer researchbiomarkershepatocellular carcinoma

presentation determines relevancepathologyradiation oncologymelanomasurgical pathologyprognostic modelhistopathologypatient survivalanatomical pathologyoncologytumoral pathology

Development of Primary Colon and Duodenal Tumor Cultures From the Apc-Mutant Pirc Rat for Screening Preventive Agents. Journal of Cancer Prevention (2025)

Immune Checkpoint Inhibitor-Mediated Hepatotoxicity: Personalized Management Based on Evolving Biochemical Behaviors. (2025)

liver physiologydrug-induced liver injurycell deathimmunologypersonalized managementhepatologyimmunotherapypharmacologyexperimental medicineevolving biochemical behaviorshepatotoxicity

Genome-Wide Association Study Identifies High-Impact Susceptibility Loci for Hcc in North America. Hepatology (2024)

high-impact susceptibility lociepidemiologyhepatologyhematologygenomicsnorth americagenome-wide association studieshuman geneticsgenetics

Richard K YangHector AlvarezAntony San LucasSinchita Roy-ChowdhuriAsif RashidHui ChenLeomar Y BallesterKeith SweeneyMark J RoutbortKeyur P PatelRajyalakshmi LuthraL Jeffrey MedeirosGokce A Toruner

mismatch repair proteinscancer geneticsmicrosatellite instability

Severe Febrile Neutropenia and Pancytopenia in a Patient With Advanced Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab: A Case Report. Journal of Gastrointestinal Oncology (2024)

Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Patients With Resectable Hepatocellular Carcinoma. Oncology (2024)

1
2
3
4
5
37
10 / page